129 related articles for article (PubMed ID: 38442613)
1. Discovery of the 2,4-disubstituted quinazoline derivative as a novel neddylation inhibitor for tumor therapy.
Su J; Li M; Chang Y; Jia M; Zhao M; Guan S; Niu J; Zhang S; Yang H; Sun M
Bioorg Chem; 2024 Apr; 145():107237. PubMed ID: 38442613
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel benzothiazole derivatives as inhibitors of NEDDylation pathway to inhibit the progression of gastric cancer.
Wang X; Zhao M; Chang Y; Guan S; Li M; Yang H; Sun M
Bioorg Med Chem Lett; 2024 Mar; 100():129647. PubMed ID: 38320715
[TBL] [Abstract][Full Text] [Related]
3. Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer.
Li L; Kang J; Zhang W; Cai L; Wang S; Liang Y; Jiang Y; Liu X; Zhang Y; Ruan H; Chen G; Wang M; Jia L
EBioMedicine; 2019 Jul; 45():81-91. PubMed ID: 31208947
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 1,2,4-triazine-based derivatives as novel neddylation inhibitors and anticancer activity studies against gastric cancer MGC-803 cells.
Song J; Cui XX; Wu BW; Li D; Wang SH; Shi L; Zhu T; Zhang YB; Zhang SY
Bioorg Med Chem Lett; 2020 Jan; 30(2):126791. PubMed ID: 31740251
[TBL] [Abstract][Full Text] [Related]
5. Flavokawain B targets protein neddylation for enhancing the anti-prostate cancer effect of Bortezomib via Skp2 degradation.
Li X; Pham V; Tippin M; Fu D; Rendon R; Song L; Uchio E; Hoang BH; Zi X
Cell Commun Signal; 2019 Mar; 17(1):25. PubMed ID: 30885218
[TBL] [Abstract][Full Text] [Related]
6. Overactivated neddylation pathway as a therapeutic target in lung cancer.
Li L; Wang M; Yu G; Chen P; Li H; Wei D; Zhu J; Xie L; Jia H; Shi J; Li C; Yao W; Wang Y; Gao Q; Jeong LS; Lee HW; Yu J; Hu F; Mei J; Wang P; Chu Y; Qi H; Yang M; Dong Z; Sun Y; Hoffman RM; Jia L
J Natl Cancer Inst; 2014 Jun; 106(6):dju083. PubMed ID: 24853380
[TBL] [Abstract][Full Text] [Related]
7. Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells.
Wang Y; Luo Z; Pan Y; Wang W; Zhou X; Jeong LS; Chu Y; Liu J; Jia L
Cancer Biol Ther; 2015; 16(3):420-9. PubMed ID: 25782162
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel tertiary amide derivatives as NEDDylation pathway activators to inhibit the tumor progression in vitro and in vivo.
Fu DJ; Song J; Zhu T; Pang XJ; Wang SH; Zhang YB; Wu BW; Wang JW; Zi X; Zhang SY; Liu HM
Eur J Med Chem; 2020 Apr; 192():112153. PubMed ID: 32135407
[TBL] [Abstract][Full Text] [Related]
9. Targeting DCN1-UBC12 Protein-Protein Interaction for Regulation of Neddylation Pathway.
Zhou H; Lu J; Yang CY; Sun Y; Wang S
Adv Exp Med Biol; 2020; 1217():349-362. PubMed ID: 31898237
[TBL] [Abstract][Full Text] [Related]
10. Discovery of candesartan cilexetic as a novel neddylation inhibitor for suppressing tumor growth.
Ni S; Chen X; Yu Q; Xu Y; Hu Z; Zhang J; Zhang W; Li B; Yang X; Mao F; Huang J; Sun Y; Li J; Jia L
Eur J Med Chem; 2020 Jan; 185():111848. PubMed ID: 31732254
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 1,2,4-triazine dithiocarbamate derivatives as NEDDylation agonists to inhibit gastric cancers.
Song J; Liu Y; Yuan XY; Liu WB; Li YR; Yu GX; Tian XY; Zhang YB; Fu XJ; Zhang SY
Eur J Med Chem; 2021 Dec; 225():113801. PubMed ID: 34455358
[TBL] [Abstract][Full Text] [Related]
12. TAS4464, A Highly Potent and Selective Inhibitor of NEDD8-Activating Enzyme, Suppresses Neddylation and Shows Antitumor Activity in Diverse Cancer Models.
Yoshimura C; Muraoka H; Ochiiwa H; Tsuji S; Hashimoto A; Kazuno H; Nakagawa F; Komiya Y; Suzuki S; Takenaka T; Kumazaki M; Fujita N; Mizutani T; Ohkubo S
Mol Cancer Ther; 2019 Jul; 18(7):1205-1216. PubMed ID: 31092565
[TBL] [Abstract][Full Text] [Related]
13. SOMCL-19-133, a novel, selective, and orally available inhibitor of NEDD8-activating enzyme (NAE) for cancer therapy.
Zhou LN; Xiong C; Cheng YJ; Song SS; Bao XB; Huan XJ; Wang TY; Zhang A; Miao ZH; He JX
Neoplasia; 2022 Oct; 32():100823. PubMed ID: 35907292
[TBL] [Abstract][Full Text] [Related]
14. Antibody-free detection of cellular neddylation dynamics of Cullin1.
Schwinn MK; Hoang T; Yang X; Zhao X; Ma J; Li P; Wood KV; Mallender WD; Bembenek ME; Yan ZH
Anal Biochem; 2018 Aug; 555():67-72. PubMed ID: 29733811
[TBL] [Abstract][Full Text] [Related]
15. A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification.
Xu B; Deng Y; Bi R; Guo H; Shu C; Shah NK; Chang J; Liu G; Du Y; Wei W; Wang C
Cancer Chemother Pharmacol; 2018 Jun; 81(6):1083-1093. PubMed ID: 29667067
[TBL] [Abstract][Full Text] [Related]
16. Development of novel benzimidazole-derived neddylation inhibitors for suppressing tumor growth invitro and invivo.
Chen X; Yang X; Mao F; Wei J; Xu Y; Li B; Zhu J; Ni S; Jia L; Li J
Eur J Med Chem; 2021 Jan; 210():112964. PubMed ID: 33129593
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a cinnamyl piperidine derivative as new neddylation inhibitor for gastric cancer treatment.
Wang B; Zhang QH; Li XJ; Wang SQ; Chen XB; Yu B; Liu HM
Eur J Med Chem; 2021 Dec; 226():113896. PubMed ID: 34624825
[TBL] [Abstract][Full Text] [Related]
18. Gartanin is a novel NEDDylation inhibitor for induction of Skp2 degradation, FBXW2 expression, and autophagy.
Pham V; Rendon R; Le VX; Tippin M; Fu DJ; Le TH; Miller M; Agredano E; Cedano J; Zi X
Mol Carcinog; 2020 Feb; 59(2):193-201. PubMed ID: 31782573
[TBL] [Abstract][Full Text] [Related]
19. Discovery of dual tubulin-NEDDylation inhibitors with antiproliferative activity.
Fu DJ; Wang T
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):166-175. PubMed ID: 36330714
[TBL] [Abstract][Full Text] [Related]
20. Suppression of glioblastoma by targeting the overactivated protein neddylation pathway.
Hua W; Li C; Yang Z; Li L; Jiang Y; Yu G; Zhu W; Liu Z; Duan S; Chu Y; Yang M; Zhang Y; Mao Y; Jia L
Neuro Oncol; 2015 Oct; 17(10):1333-43. PubMed ID: 25904638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
